Director of Operations
National Cancer Institute
Dr. Dobrovolskaia is Laboratory Director of Operations and the Head of Immunology Section at the Nanotechnology Characterization Laboratory (NCL). Dr. Dobrovolskaia leads a team conducting preclinical studies supporting the translation of cancer nanotechnology therapeutics. Prior to joining the NCL, Dr. Dobrovolskaia worked as a Research Scientist in a GLP laboratory at PPD Development, Inc. in Richmond, VA, where she was responsible for the design, development, and validation of bioanalytical ligand-binding assays to support pharmacokinetic and toxicity studies in a variety of drug development projects. She received her M.S. degree from the Kazan State University in Russia; Ph.D. from the N.N. Blokhin Cancer Research Center of the Russian Academy of Medical Sciences in Moscow, Russia; and MBA from the Hood College in Frederick, MD. Since 2016, she is also a member of the Project Management Institute and a certified Project Management Professional. Her research interests include immunology, toxicology, nanotechnology, and bioanalytical methodology. Dr. Dobrovolskaia’s list of publications and citations of the published work can be accessed via the following link https://scholar.google.com/citations?user=Biz76XAAAAAJ&hl=en